Strategies are being developed to increase the secretion of pro-inflammatory chemokines and improve the infiltration of immune cells in the tumor such as targeting HIF-1α, which resulted in an increase in the pro-inflammatory chemokine CCL5 and an increase in the infiltration of CD4+ and CD8+ T cells as well as NK cells [40]. The gene discussed is CCL5; the disease is neoplasm.